Short-Term GLP-1 Co-Administration for MOUD and MAUD in Clinics Does semaglutide or tirzepatide (given at first visit and ongoing) along with existing MOUD or MAUD increase success rates over a 3 month period
Other weight-loss drugs approved for long-term use, like naltrexone/bupropion (Contrave) and phentermine/topiramate (Qsymia), suppress your appetite in different ways, like targeting nerves in the brain
Additionally, it aids in energy production, helping to improve exercise endurance and overall vitality
This step is consistently cited as the contamination-prevention checkpoint
To answer this paradigm shift, solutions include: Portfolio modification , notably through acquisitions of health-focused brands (such as Pepsicos acquisitions of Siete Foods and Poppi earlier this year) GLP-1 companions : development of products aimed at reducing the after effects of the drug through muscle preservation, gut-health and also at providing a natural booster effect to the drug